1. Home
  2. IRD vs NCEW Comparison

IRD vs NCEW Comparison

Compare IRD & NCEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRD
  • NCEW
  • Stock Information
  • Founded
  • IRD 2018
  • NCEW 2002
  • Country
  • IRD United States
  • NCEW Hong Kong
  • Employees
  • IRD N/A
  • NCEW N/A
  • Industry
  • IRD
  • NCEW
  • Sector
  • IRD
  • NCEW
  • Exchange
  • IRD NYSE
  • NCEW NYSE
  • Market Cap
  • IRD 62.0M
  • NCEW 25.4M
  • IPO Year
  • IRD N/A
  • NCEW 2024
  • Fundamental
  • Price
  • IRD $1.02
  • NCEW $0.95
  • Analyst Decision
  • IRD Strong Buy
  • NCEW
  • Analyst Count
  • IRD 3
  • NCEW 0
  • Target Price
  • IRD $6.33
  • NCEW N/A
  • AVG Volume (30 Days)
  • IRD 803.8K
  • NCEW 595.3K
  • Earning Date
  • IRD 08-15-2025
  • NCEW 08-15-2025
  • Dividend Yield
  • IRD N/A
  • NCEW N/A
  • EPS Growth
  • IRD N/A
  • NCEW N/A
  • EPS
  • IRD N/A
  • NCEW 0.01
  • Revenue
  • IRD $13,651,000.00
  • NCEW $52,176,109.00
  • Revenue This Year
  • IRD $51.41
  • NCEW N/A
  • Revenue Next Year
  • IRD $68.84
  • NCEW N/A
  • P/E Ratio
  • IRD N/A
  • NCEW $85.34
  • Revenue Growth
  • IRD N/A
  • NCEW 44.64
  • 52 Week Low
  • IRD $0.65
  • NCEW $0.88
  • 52 Week High
  • IRD $2.18
  • NCEW $4.15
  • Technical
  • Relative Strength Index (RSI)
  • IRD N/A
  • NCEW N/A
  • Support Level
  • IRD N/A
  • NCEW N/A
  • Resistance Level
  • IRD N/A
  • NCEW N/A
  • Average True Range (ATR)
  • IRD 0.00
  • NCEW 0.00
  • MACD
  • IRD 0.00
  • NCEW 0.00
  • Stochastic Oscillator
  • IRD 0.00
  • NCEW 0.00

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA), and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

About NCEW NEW CENTURY LOGISTICS (BVI) LIMITED

New Century Logistics (BVI) Ltd is a well-established freight forwarding service provider based in Hong Kong. The company provides air and ocean export and import freight forwarding services ranging from the sale of cargo space, cargo pick up, off-airport air cargo security screening, palletization, preparation of shipping documentation, and arrangement of customs clearance to cargo handling at ports. It provides a full range of logistics services by providing to its customers with a robust international network that strategically supports the movement of its customers' goods. Includes various logistic like New Century Logistics Company Limited, GLF Cargo Services Limited, Win-Tec Transportation Company Limited.

Share on Social Networks: